Chronic hepatitis C: early intervention
- PMID: 9636354
- DOI: 10.1080/21548331.1998.11443707
Chronic hepatitis C: early intervention
Abstract
Chronic hepatitis C infection is the most common liver disease in the United States; it accounts for up to 12,000 deaths annually and is the most common referral for liver transplantation. Recognition of acute infection is desirable because treatment may prevent chronicity. Interferon remains the primary treatment, but new agents and combinations are being developed.
Similar articles
-
Interferon in wonderland.Gastroenterology. 1998 Oct;115(4):1027-9. doi: 10.1016/s0016-5085(98)70284-7. Gastroenterology. 1998. PMID: 9786731 No abstract available.
-
Interferon alfa for chronic hepatitis C infection.Lancet. 1999 Feb 6;353(9151):499-500. doi: 10.1016/s0140-6736(05)75173-4. Lancet. 1999. PMID: 9989747 No abstract available.
-
Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.JAMA. 1998 Dec 23-30;280(24):2088-93. doi: 10.1001/jama.280.24.2088. JAMA. 1998. PMID: 9875876
-
Combination therapy for chronic hepatitis C: interferon and ribavirin.Hosp Med. 1999 May;60(5):357-61. doi: 10.12968/hosp.1999.60.5.1116. Hosp Med. 1999. PMID: 10396412 Review.
-
Diagnosis and treatment of hepatitis C.J R Soc Med. 2004 May;97(5):223-5. doi: 10.1177/014107680409700504. J R Soc Med. 2004. PMID: 15121811 Free PMC article. Review. No abstract available.
Cited by
-
Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City.Am J Public Health. 2002 Aug;92(8):1254-6. doi: 10.2105/ajph.92.8.1254. Am J Public Health. 2002. PMID: 12144980 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources